P0125 Bone metastasis enrichment factor SHMT2 mediates immunosuppressive microenvironment and drives prostate cancer progression via the PI3K/AKT/mTOR pathway

European Urology 2026

View at publisher

Authors: Y. Lai, H. Zhong, Z. Wu, Z. Guo, S. Peng, H. Huang

DOI: 10.1016/s0302-2838(26)01035-3

Cited by: 0

Fields of Study & Subjects

Prostate Cancer Treatment and Research PI3K/AKT/mTOR signaling in cancer Cancer Immunotherapy and Biomarkers